Endo Inc. announced the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®?. The medication is used in combination with high fluid intake, alkali (low acid), and dietary changes to help prevent the formation of one type (cystine) of kidney stones in certain adult and pediatric patients. As a demonstration of its commitment to patients, Endo is offering copay assistance for those who meet eligibility requirements.

To learn more about Endo's Patient Assistance Program, patients can call (833)727-4357. THIOLA EC®®? is a registered trademark of Mission Pharmacal Company.